Featured Firms
Presented by BigVoodoo
Bolstered by last year's revisions to the Hatch-Waxman Act, generic companies are increasingly challenging lucrative patents, spurred on by U.S. consumers' cry for less expensive medications. Practitioners are also seeing more claims that patent settlements between pharmaceutical companies and generics violate antitrust laws. The result is law firms are funneling more resources into entering the pharmaceutical fray.
September 07, 2004 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS